FDA approves a new generic valsartan

FDA

12 March 2019 - Today, the U.S. FDA approved a new generic of Diovan (valsartan). 

Valsartan is an angiotensin II receptor blocker that treats high blood pressure and heart failure. 

The FDA prioritised the review of this drug application to help relieve the recent shortage of this critical medicine as a result of multiple recalls of generic valsartan products from several manufacturers due to the finding that certain lots of valsartan and other ARB medicines contain nitrosamine impurities.

Read FDA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , US , Generic medicine